FFAR2 and Alzheimer disease: Notably, TUNEL assays and flow cytometry reveal that GPR43 overexpression reduces the number of apoptotic bodies, suggesting that GPR43 overexpression reduces the number of apoptotic bodies, suggesting that GPR43 inhibits apoptosis in AD mice.